The ECJ’s Illumina/Grail judgment has curtailed the Commission’s direct oversight of certain transactions, thereby elevating the need for national "call-in" powers. These call-in regimes, which are proliferating both inside...more
Das Bundeskartellamt nimmt derzeit verstärkt zu den kartellrechtlichen Grenzen bei Preissteigerungen Stellung. Bundeskartellamt zu der aktuellen Entwicklung der Kraftstoffpreise Auf Veranlassung von Wirtschaftsminister Habeck...more
In the much-anticipated Lundbeck case (i.a. C-591/16 P), the European Court of Justice (“ECJ”) on 25th March 2021 confirmed the decision of the European Commission (“Commission”) to impose fines on Lundbeck and several...more
4/21/2021
/ Anti-Competitive ,
Antitrust Provisions ,
Competition ,
Drug Distribution ,
Duty of Care ,
European Commission ,
European Court of Justice (ECJ) ,
Generic Drugs ,
Life Sciences ,
Pay-For-Delay ,
Pharmaceutical Industry
Settlements are a frequently used means of efficiently terminating proceedings, not only in cartel cases but also in other antitrust proceedings. The EU Commission can avoid having to spend resources on a time-consuming...more
12/16/2020
/ Antitrust Litigation ,
Antitrust Violations ,
Contract Terms ,
EU ,
European Commission ,
European Court of Justice (ECJ) ,
European Economic Area (EEA) ,
Exclusivity ,
Film Industry ,
Licensing Rules ,
Luxembourg ,
Movies ,
Paramount Pictures ,
Settlement Agreements ,
Television Broadcast Stations ,
Third-Party Service Provider